Edwards Lifesciences’ SAPIEN M3 becomes first FDA-approved transseptal mitral valve replacement
The SAPIEN M3 transcatheter mitral valve replacement (TMVR) system is designed for patients with symptomatic moderate-to-severe or severe MR
The SAPIEN M3 transcatheter mitral valve replacement (TMVR) system is designed for patients with symptomatic moderate-to-severe or severe MR
Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
The valve has a saddle-shaped sewing cuff that mimics the asymmetric shape of the native mitral valve
Subscribe To Our Newsletter & Stay Updated